{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/skin-cancers-recognition-referral/management/referral-for-suspected-skin-cancer/","result":{"pageContext":{"chapter":{"id":"84a65bbe-088b-5e3c-904a-1d6d456b81d9","slug":"referral-for-suspected-skin-cancer","fullItemName":"Scenario: Referral for suspected skin cancer","depth":2,"htmlHeader":"<!-- begin field a72e5ce2-06f9-4906-89d6-78353bea7f6f --><h2>Scenario: Referral for suspected skin cancer</h2><!-- end field a72e5ce2-06f9-4906-89d6-78353bea7f6f -->","summary":"Covers the referral of people with suspected skin cancer.","htmlStringContent":"<!-- begin item 76c8c852-c371-4be8-a6b8-d4fe74f1349b --><!-- begin field 1865d3f3-2e12-45fa-9803-acd900ad5cdb --><p>From birth onwards.</p><!-- end field 1865d3f3-2e12-45fa-9803-acd900ad5cdb --><!-- end item 76c8c852-c371-4be8-a6b8-d4fe74f1349b -->","topic":{"id":"b5e958f7-3b89-58c9-948d-c9405fa255f1","topicId":"dabd3469-1c63-4dec-83b4-28c443c7d5c3","topicName":"Skin cancers - recognition and referral","slug":"skin-cancers-recognition-referral","lastRevised":"Last revised in February 2021","chapters":[{"id":"e6ee527d-5fc4-5ac8-940b-93f94ac104a6","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"ebef9550-592f-5898-8ba3-9ea38bb51c17","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"b3e81aa2-1b6a-5eee-92a5-4f0591335062","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"a4d2fff4-bef2-5d6b-908a-5857d3524985","slug":"changes","fullItemName":"Changes"},{"id":"f271a541-7dd3-570a-b689-00c0ed3f49cd","slug":"update","fullItemName":"Update"}]},{"id":"6ab1ee1c-d33f-5ca5-a1aa-164a4dfd7590","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"fdcb91b4-39e3-5e03-9ba0-8408c9b26787","slug":"goals","fullItemName":"Goals"},{"id":"d4f6d2c2-6eac-5296-8598-6c238dde918f","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"4ca236ab-c8af-5074-813f-6751f92b4952","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"453c2ce2-aae0-54e6-b588-f050c8756fc8","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"fca6abcb-8894-55ac-ace0-2f1e73ea1c88","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"b70134e6-a170-574e-9aaf-20ca21d176b3","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"878832f3-50e3-55b4-bb30-1f029b12e026","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"a2f82ecf-cbbe-5cab-b108-fc4f33bedc75","slug":"presentation","fullItemName":"Presentation"},{"id":"a2c00f92-b4a0-576b-8fa6-8fcfe531d3bd","slug":"prevalence","fullItemName":"Prevalence"},{"id":"de0d3bf5-55cc-5aa2-b92e-cd65ce4db1d1","slug":"prognosis","fullItemName":"Prognosis"}]},{"id":"8828f7f1-f440-5e24-ad37-fb8fa724e106","fullItemName":"Diagnosis","slug":"diagnosis","subChapters":[{"id":"02d468ee-c39c-5f9d-af75-cb54a18f8b5d","slug":"symptoms-suggestive-of-skin-cancers","fullItemName":"Symptoms suggestive of skin cancers"}]},{"id":"4f5a47f8-af5c-5097-95de-4223da68a4bf","fullItemName":"Management","slug":"management","subChapters":[{"id":"84a65bbe-088b-5e3c-904a-1d6d456b81d9","slug":"referral-for-suspected-skin-cancer","fullItemName":"Scenario: Referral for suspected skin cancer"}]},{"id":"19bfedff-b5c3-59b7-97ec-72eb07dd43dc","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"dfb84bee-0680-502f-8a48-c8d6479f6b75","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"0cca9a03-1905-595b-965b-d89c97f7ffc8","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"26c87a9d-e6f5-5173-bae8-1b06114ad377","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"87f57bb7-7e22-5297-8f45-4b43633faaf2","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"87c3517e-206e-5415-ad9c-94aadef9c707","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"b0711e04-85fb-5549-97ed-2e279415ed98","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"e77325d6-c5c8-5292-b2e8-742bc8134664","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"4f5a47f8-af5c-5097-95de-4223da68a4bf","slug":"management","fullItemName":"Management"},"subChapters":[{"id":"1855f01c-ac35-511d-b49d-d5ad9480cb74","slug":"referral-timelines","fullItemName":"Referral timelines","depth":3,"htmlHeader":"<!-- begin field b8ad5067-72f9-4743-9486-4cb03b040d49 --><h3>Referral timelines</h3><!-- end field b8ad5067-72f9-4743-9486-4cb03b040d49 -->","summary":null,"htmlStringContent":"<!-- begin item 453baada-481c-4c2e-b841-8660d1f2a785 --><!-- begin field 7af01f38-5ae3-4b70-9b55-13722a9ee3c3 --><ul><li>The terms used in the National Institute for Health and Care Excellence (NICE) guideline <em>Suspected cancer: recognition and referral</em> are as follows:<br><ul><li>Immediate: an acute admission or referral occurring within a few hours, or even more quickly if necessary.</li><li>Urgent: to happen/be performed within 2 weeks.</li><li>Very urgent: to happen within 48 hours.</li><li>Non-urgent: the timescale generally used for a referral or investigation that is not considered very urgent or urgent.</li><li>Suspected cancer pathway referral: the patient is seen within the national target for cancer referrals.</li></ul></li></ul><!-- end field 7af01f38-5ae3-4b70-9b55-13722a9ee3c3 --><!-- end item 453baada-481c-4c2e-b841-8660d1f2a785 -->","subChapters":[{"id":"da284048-a4e2-5b0c-8216-59157ea7b2df","slug":"basis-for-recommendation-7c8","fullItemName":"Basis for recommendation","depth":4,"htmlHeader":"<!-- begin field 9998ff38-d6fd-4aac-a09e-cbe8a93c9bd9 --><h4>Basis for recommendation</h4><!-- end field 9998ff38-d6fd-4aac-a09e-cbe8a93c9bd9 -->","summary":null,"htmlStringContent":"<!-- begin item 7c8dfb8f-799f-40b3-8e48-4069a899d321 --><!-- begin field 5737b3f5-1819-40ab-8435-2e1082afad4e --><p>This is a direct implementation of the National Institute for Health and Care Excellence guideline <em>Suspected cancer: recognition and r</em><em>eferral</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/skin-cancers-recognition-referral/references/\">NICE, 2015</a>].</p><!-- end field 5737b3f5-1819-40ab-8435-2e1082afad4e --><!-- end item 7c8dfb8f-799f-40b3-8e48-4069a899d321 -->","subChapters":[]}]},{"id":"fcbcc9c2-5835-5891-9865-73ddb764c03c","slug":"referral-for-suspected-malignant-melanoma-of-the-skin","fullItemName":"Referral for suspected malignant melanoma of the skin","depth":3,"htmlHeader":"<!-- begin field afaff795-8b58-40c6-acd3-d176f1f10778 --><h3>Referral for suspected malignant melanoma of the skin</h3><!-- end field afaff795-8b58-40c6-acd3-d176f1f10778 -->","summary":null,"htmlStringContent":"<!-- begin item 5af472e3-588f-4bcf-9a16-760190769f32 --><!-- begin field cb0ba2e2-2147-416d-8248-8539f073b0a1 --><ul><li><strong>Refer people using a suspected cancer pathway referral </strong>(for an appointment within 2 weeks) for melanoma if they have a suspicious pigmented skin lesion with a weighted 7-point checklist score of 3 or more.</li></ul><p>Weighted 7-point checklist:</p><ul><li>Major features of the lesions (scoring 2 points each):<ul><li>Change in size.</li><li>Irregular shape.</li><li>Irregular colour.</li></ul></li><li>Minor features of the lesions (scoring 1 point each):<ul><li>Largest diameter 7 mm or more.</li><li>Inflammation.</li><li>Oozing.</li><li>Change in sensation.</li></ul></li><li><strong>Refer people using a suspected cancer pathway referral </strong>(for an appointment within 2 weeks) if dermoscopy suggests melanoma of the skin.</li><li><strong>Consider a suspected cancer pathway referral </strong>(for an appointment within 2 weeks) for melanoma in people with a pigmented or non-pigmented skin lesion that suggests nodular melanoma.</li></ul><!-- end field cb0ba2e2-2147-416d-8248-8539f073b0a1 --><!-- end item 5af472e3-588f-4bcf-9a16-760190769f32 -->","subChapters":[{"id":"871164d4-0e26-5e9a-aea1-34d6283f1ab7","slug":"basis-for-recommendation-936","fullItemName":"Basis for recommendation","depth":4,"htmlHeader":"<!-- begin field 784fa626-25bc-4924-bf59-db8c625db233 --><h4>Basis for recommendation</h4><!-- end field 784fa626-25bc-4924-bf59-db8c625db233 -->","summary":null,"htmlStringContent":"<!-- begin item 9369c0aa-1e88-4310-a93d-2f14a4fc5790 --><!-- begin field 89d9ca88-0ef9-429f-a73a-f71e32f79b48 --><p>This is a direct implementation of the National Institute for Health and Care Excellence guideline <em>Suspected cancer: recognition and r</em><em>eferral</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/skin-cancers-recognition-referral/references/\">NICE, 2015</a>].</p><!-- end field 89d9ca88-0ef9-429f-a73a-f71e32f79b48 --><!-- end item 9369c0aa-1e88-4310-a93d-2f14a4fc5790 -->","subChapters":[]}]},{"id":"bd4b47d6-1d90-558f-a848-28f74f76c2df","slug":"referral-for-suspected-squamous-cell-carcinoma","fullItemName":"Referral for suspected squamous cell carcinoma","depth":3,"htmlHeader":"<!-- begin field 33d2b4f1-1cb7-41b8-ab18-b92453e8b0dc --><h3>Referral for suspected squamous cell carcinoma</h3><!-- end field 33d2b4f1-1cb7-41b8-ab18-b92453e8b0dc -->","summary":null,"htmlStringContent":"<!-- begin item e81a51ee-6c85-4b36-b1d4-795ec6d72fa5 --><!-- begin field 4161537a-6576-4f63-93fe-225ea9961bcc --><ul><li><strong>Consider a suspected cancer pathway referral </strong>(for an appointment within 2 weeks) for people with a skin lesion that raises the suspicion of squamous cell carcinoma.</li></ul><!-- end field 4161537a-6576-4f63-93fe-225ea9961bcc --><!-- end item e81a51ee-6c85-4b36-b1d4-795ec6d72fa5 -->","subChapters":[{"id":"6e64b672-0fb9-5d9f-af93-f428b3bce67d","slug":"basis-for-recommendation-f05","fullItemName":"Basis for recommendation","depth":4,"htmlHeader":"<!-- begin field 27605a60-6ad7-47b0-98f2-c754d22028ef --><h4>Basis for recommendation</h4><!-- end field 27605a60-6ad7-47b0-98f2-c754d22028ef -->","summary":null,"htmlStringContent":"<!-- begin item f05c8cd2-76c4-4f25-a4ef-093d1781e12c --><!-- begin field fd8f6408-a5ff-4bff-a2d9-ad55375c481d --><p>This is a direct implementation of the National Institute for Health and Care Excellence guideline <em>Suspected cancer: recognition and r</em><em>eferral</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/skin-cancers-recognition-referral/references/\">NICE, 2015</a>].</p><!-- end field fd8f6408-a5ff-4bff-a2d9-ad55375c481d --><!-- end item f05c8cd2-76c4-4f25-a4ef-093d1781e12c -->","subChapters":[]}]},{"id":"44265a4b-57b9-5f28-9007-3b50d7443491","slug":"referral-for-suspected-basal-cell-carcinoma","fullItemName":"Referral for suspected basal cell carcinoma","depth":3,"htmlHeader":"<!-- begin field b867f39b-adaa-40c2-b063-9986c0528bfb --><h3>Referral for suspected basal cell carcinoma</h3><!-- end field b867f39b-adaa-40c2-b063-9986c0528bfb -->","summary":null,"htmlStringContent":"<!-- begin item e1f68649-8936-4152-962c-b514fe9d78e2 --><!-- begin field 907c275c-1ad7-4748-a926-72a20bd92946 --><ul><li><strong>Consider routine referral for people if they have a skin lesion that raises the suspicion of a basal cell carcinoma.</strong></li><li><strong>Only consider a suspected cancer pathway referral (for an appointment within 2 weeks) for people with a skin lesion that raises the suspicion of a basal cell carcinoma if there is particular concern that a delay may have a significant impact,</strong> because of factors such as lesion site or size.</li></ul><!-- end field 907c275c-1ad7-4748-a926-72a20bd92946 --><!-- end item e1f68649-8936-4152-962c-b514fe9d78e2 -->","subChapters":[{"id":"adba93bf-fb2b-53cf-892d-970c95521b67","slug":"basis-for-recommendation-0de","fullItemName":"Basis for recommendation","depth":4,"htmlHeader":"<!-- begin field cd2db1a4-48aa-4e1d-916f-5e50afde1fdb --><h4>Basis for recommendation</h4><!-- end field cd2db1a4-48aa-4e1d-916f-5e50afde1fdb -->","summary":null,"htmlStringContent":"<!-- begin item 0de91ad8-cf66-4f0b-b2e3-f037e97763b1 --><!-- begin field 7113a567-b9bf-44d3-b639-10395994bfbd --><p>This is a direct implementation of the National Institute for Health and Care Excellence guideline <em>Suspected cancer: recognition and r</em><em>eferral</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/skin-cancers-recognition-referral/references/\">NICE, 2015</a>].</p><!-- end field 7113a567-b9bf-44d3-b639-10395994bfbd --><!-- end item 0de91ad8-cf66-4f0b-b2e3-f037e97763b1 -->","subChapters":[]}]},{"id":"d03def98-f5bf-5785-bb0a-866de8e9f5fd","slug":"diagnostic-referral-process","fullItemName":"Diagnostic and referral process","depth":3,"htmlHeader":"<!-- begin field ce960afc-8657-4287-b88d-77321ac7c721 --><h3>Diagnostic and referral process</h3><!-- end field ce960afc-8657-4287-b88d-77321ac7c721 -->","summary":null,"htmlStringContent":"<!-- begin item d844ba08-91c2-43ed-9db1-1eafb41f0091 --><!-- begin field d654847a-14a8-4a3a-b5ba-7db519e77e94 --><ul><li>Discussion with a specialist (for example, by telephone or email) should be considered if there is uncertainty about the interpretation of symptoms and signs, and whether a referral is needed. This may also enable the primary healthcare professional to communicate their concerns and a sense of urgency to secondary healthcare professionals when symptoms are not classical.</li><li>Put in place local arrangements to ensure that letters about non-urgent referrals are assessed by the specialist, so that the person can be seen more urgently if necessary.</li><li>Put in place local arrangements to ensure that there is a maximum waiting period for non-urgent referrals, in accordance with national targets and local arrangements.</li><li>Ensure local arrangements are in place to identify people who miss their appointments so that they can be followed up.</li><li>Include all appropriate information in referral correspondence, including whether the referral is urgent or non-urgent.</li><li>Use local referral proformas if these are in use.</li><li>Once the decision to refer has been made, make sure that the referral is made within 1 working day.</li><li>Take part in continuing education, peer review, and other activities to improve and maintain clinical consulting, reasoning, and diagnostic skills, in order to identify at an early stage people who may have cancer, and to communicate the possibility of cancer to the person.</li></ul><!-- end field d654847a-14a8-4a3a-b5ba-7db519e77e94 --><!-- end item d844ba08-91c2-43ed-9db1-1eafb41f0091 -->","subChapters":[{"id":"f545652f-9716-5abb-99cf-0371b1564161","slug":"basis-for-recommendation-674","fullItemName":"Basis for recommendation","depth":4,"htmlHeader":"<!-- begin field 463cd4f7-d791-40f2-95dd-379cc30da4ae --><h4>Basis for recommendation</h4><!-- end field 463cd4f7-d791-40f2-95dd-379cc30da4ae -->","summary":null,"htmlStringContent":"<!-- begin item 674d1a5c-86c5-443e-a5de-db529418293d --><!-- begin field b1be8327-5f2c-4ac0-a0eb-8660840babbc --><p>This is a direct implementation of the National Institute for Health and Care Excellence guideline <em>Suspected cancer: recognition and r</em><em>eferral</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/skin-cancers-recognition-referral/references/\">NICE, 2015</a>].</p><!-- end field b1be8327-5f2c-4ac0-a0eb-8660840babbc --><!-- end item 674d1a5c-86c5-443e-a5de-db529418293d -->","subChapters":[]}]},{"id":"3bdfae7c-6a3d-5f26-b3a0-d1a41dafb5ec","slug":"patient-information-support","fullItemName":"Patient information and support","depth":3,"htmlHeader":"<!-- begin field e5411803-ebdb-447d-9c52-5a39c009c502 --><h3>Patient information and support</h3><!-- end field e5411803-ebdb-447d-9c52-5a39c009c502 -->","summary":null,"htmlStringContent":"<!-- begin item f1784bfc-49bc-4960-99a6-954f3d78514e --><!-- begin field 68a781b6-6922-443f-b580-0193bcf68734 --><ul><li>Discuss with people with suspected cancer (and their carers as appropriate, taking account of the need for confidentiality) their preferences for being involved in decision-making about referral options and further investigations including their potential risks and benefits.</li><li>Explain to people who are being referred with suspected cancer that they are being referred to a cancer service. Reassure them, as appropriate, that most people referred will not have a diagnosis of cancer, and discuss alternative diagnoses with them.</li><li>Give the person information on the possible diagnosis (both benign and malignant) in accordance with their wishes for information.</li><li>The information given to people with suspected cancer and their families and/or carers should cover, among other issues:<ul><li>Where the person is being referred to.</li><li>How long they will have to wait for the appointment.</li><li>How to obtain further information about the type of cancer suspected or help before the specialist appointment.</li><li>What to expect from the service the person will be attending.</li><li>What type of tests may be carried out, and what will happen during diagnostic procedures.</li><li>How long it will take to get a diagnosis or test results.</li><li>Whether they can take someone with them to the appointment.</li><li>Who to contact if they do not receive confirmation of an appointment.</li><li>Other sources of support.</li></ul></li><li>Provide information that is appropriate for the person in terms of language, ability, and culture, recognizing the potential for different cultural meanings associated with the possibility of cancer.</li><li>Have information available in a variety of formats on both local and national sources of information and support for people who are being referred with suspected cancer.</li><li>When referring a person with suspected cancer to a specialist service, assess their need for continuing support while waiting for their referral appointment. This should include inviting the person to contact their healthcare professional again if they have more concerns or questions before they see a specialist.</li><li>If the person has additional support needs because of their personal circumstances, inform the specialist (with the person's agreement).</li><li>When cancer is suspected in a child, discuss the referral decision and information to be given to the child with the parents or carers (and the child if appropriate).</li></ul><!-- end field 68a781b6-6922-443f-b580-0193bcf68734 --><!-- end item f1784bfc-49bc-4960-99a6-954f3d78514e -->","subChapters":[{"id":"928ec454-565c-554a-89e4-42f12b06e28a","slug":"basis-for-recommendation-7b6","fullItemName":"Basis for recommendation","depth":4,"htmlHeader":"<!-- begin field bbf7ebbe-ffeb-4d87-9a39-7cf12d156169 --><h4>Basis for recommendation</h4><!-- end field bbf7ebbe-ffeb-4d87-9a39-7cf12d156169 -->","summary":null,"htmlStringContent":"<!-- begin item 7b6d3782-16b7-4992-ad70-1501056d1d55 --><!-- begin field 695f8ffc-a7d0-49ee-9ed9-aec87cde6e33 --><p>This is a direct implementation of the National Institute for Health and Care Excellence guideline <em>Suspected cancer: recognition and referral </em>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/skin-cancers-recognition-referral/references/\">NICE, 2015</a>].</p><!-- end field 695f8ffc-a7d0-49ee-9ed9-aec87cde6e33 --><!-- end item 7b6d3782-16b7-4992-ad70-1501056d1d55 -->","subChapters":[]}]},{"id":"00b2449c-1aef-5f3f-8f6f-17a0aa72f793","slug":"safety-netting","fullItemName":"Safety netting","depth":3,"htmlHeader":"<!-- begin field dd422c9a-bd0c-460e-b222-904b37033f1c --><h3>Safety netting</h3><!-- end field dd422c9a-bd0c-460e-b222-904b37033f1c -->","summary":null,"htmlStringContent":"<!-- begin item 2f40aa91-d091-4036-b28c-f5e68c7cff65 --><!-- begin field 8e5d71b6-f842-474a-bfb7-0cb6f117d569 --><ul><li>Safety netting involves active monitoring of low risk people presenting with symptoms in primary care.</li><li>Explain to people who are being offered safety netting which symptoms to look out for and when they should return for re-evaluation. It may be appropriate to provide written information.</li><li>Reassure people in the safety netting group who are concerned that they may have cancer that with their current symptoms their risk of having cancer is low.</li><li>Ensure that the results of investigations are reviewed and acted upon appropriately, with the healthcare professional who ordered the investigation taking or explicitly passing on responsibility for this. Be aware of the possibility of false-negative results for chest X-rays and tests for occult blood in faeces.</li><li>Consider a review for people with any symptom that is associated with an increased risk of cancer, but who do not meet the criteria for referral or other investigative action. The review may be planned within a time frame agreed with the person or patient-initiated if new symptoms develop, the person continues to be concerned, or their symptoms recur, persist, or worsen.</li></ul><!-- end field 8e5d71b6-f842-474a-bfb7-0cb6f117d569 --><!-- end item 2f40aa91-d091-4036-b28c-f5e68c7cff65 -->","subChapters":[{"id":"eda6074a-ca84-59ce-9f0b-7a550a0a0111","slug":"basis-for-recommendation-4ca","fullItemName":"Basis for recommendation","depth":4,"htmlHeader":"<!-- begin field f65578d2-eaba-4080-bfe3-080042f16f9f --><h4>Basis for recommendation</h4><!-- end field f65578d2-eaba-4080-bfe3-080042f16f9f -->","summary":null,"htmlStringContent":"<!-- begin item 4ca961de-b355-4a04-9188-fdfea91ab156 --><!-- begin field 7111d3cc-e24c-4236-83a8-ca4fa44e4ebf --><p>This is a direct implementation of the National Institute for Health and Care Excellence guideline <em>Suspected cancer: recognition and r</em><em>eferral</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/skin-cancers-recognition-referral/references/\">NICE, 2015</a>].</p><!-- end field 7111d3cc-e24c-4236-83a8-ca4fa44e4ebf --><!-- end item 4ca961de-b355-4a04-9188-fdfea91ab156 -->","subChapters":[]}]}]}}},"staticQueryHashes":["3666801979"]}